MDLZ
Mondelez International, Inc.
(NASDAQ: MDLZ)
Balfour Capital Group has issued a buy recommendation
for Mondelez International, Inc. (MDLZ)Â on June 23rd, 2025
Mondelez International, Inc. (NASDAQ: MDLZ) is one of the world’s leading snack food companies, selling biscuits, chocolate, gum, candy, cheese & grocery items, and powdered beverages across more than 150 countries. Its iconic brands include Oreo, Cadbury, Milka, Ritz, Toblerone, Trident, and Tang. Headquartered in Chicago, IL, it employs around 90,000 people worldwide. In 2024, Mondelēz generated $36.4 billion in net revenue and $4.6 billion in net earnings.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $68.31 on June 23, 2025.
- Our designated price target stands at $95.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
Balfour Capital Group wants to clarify that our recommendation to Buy Mondelez International, Inc. (NASDAQ: MDLZ)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
ALKT
Alkami Technology, Inc.
(NASDAQ: ALKT)
Balfour Capital Group has issued a buy recommendation
for Alkami Technology, Inc. (ALKT)Â on June 23rd, 2025
Alkami provides cloud-based digital banking solutions tailored for financial institutions across the U.S. Their platform supports online banking, fraud prevention, marketing, user engagement, and AI-driven client insights. Based in Plano, Texas, they’ve grown significantly since their 2021 IPO.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $27.95 on June 23, 2025.
- Our designated price target stands at $44.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy Alkami Technology, Inc. (NASDAQ: ALKT)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
BMRN
BioMarin Pharmaceutical Inc.
(NASDAQ: BMRN)
Balfour Capital Group has issued a buy recommendation
for BioMarin Pharmaceutical Inc. (BMRN)Â on June 23rd, 2025
BioMarin Pharmaceutical Inc. is a global biotech firm headquartered in San Rafael, CA, specializing in enzyme replacement therapies and other treatments for rare genetic diseases. Founded in 1997, it has developed multiple orphan drugs and operates worldwide with robust R&D pipelines.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $55.00 on June 23, 2025.
- Our designated price target stands at $84.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
CRM
Salesforce, Inc.
(NYSE: CRM)
Balfour Capital Group has issued a buy recommendation
for Salesforce, Inc. (CRM)Â on June 23rd, 2025
Salesforce is a leading American cloud‑based software company specializing in Customer Relationship Management (CRM) solutions. Its flagship platform provides Sales Cloud, Service Cloud, Marketing Cloud, Commerce Cloud, Analytics (Einstein/CRM Analytics), Slack, and AI-powered tools to help businesses manage sales, service, marketing, e‑commerce, and app development—all within a unified customer-data ecosystem.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $260.63 on June 23, 2025.
- Our designated price target stands at $335.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2026 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
Balfour Capital Group wants to clarify that our recommendation to Buy Salesforce, Inc. (NYSE: CRM)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
DDOG
Datadog, Inc.
(NASDAQ: DDOG)
Balfour Capital Group has issued a buy recommendation
for Datadog, Inc. (DDOG)Â on June 17th, 2025
Datadog is a cloud-native SaaS provider specializing in observability and security for cloud-scale applications. Its unified platform monitors servers, databases, tools, and services—offering real-time metrics, logs, traces, and security monitoring in one consolidated dashboard
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $121.93 on June 17, 2025.
- Our designated price target stands at $185.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy Datadog, Inc. (NASDAQ: DDOG)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
GS
The Goldman Sachs Group, Inc.
(NYSE: GS)
Balfour Capital Group has issued a buy recommendation
for The Goldman Sachs Group, Inc. (GS)Â on June 17th, 2025
Goldman Sachs is a leading global investment bank and financial services firm founded in 1869 and headquartered in New York City. It operates through major segments: Global Banking & Markets, Asset & Wealth Management, and Platform Solutions (including direct banking). Services include M&A advisory, underwriting, trading (both flow and proprietary), prime brokerage, asset- and wealth-management, and transaction banking.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $627.85 on June 17, 2025.
- Our designated price target stands at $750.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
Balfour Capital Group wants to clarify that our recommendation to Buy The Goldman Sachs Group, Inc. (NYSE: GS)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
PBR
Petroleo Brasileiro SA Petrobras
(NYSE: PBR)
Balfour Capital Group has issued a buy recommendation
for Petroleo Brasileiro SA Petrobras (PBR)Â on June 3rd, 2025
Petrobras is Brazil’s state-controlled, vertically integrated energy company and one of the world’s largest oil and gas producers. Its operations span exploration and production (E&P), refining, transportation, marketing, and energy generation. The company is a global leader in deepwater and ultra-deepwater oil production, with a strong focus on Brazil’s offshore pre-salt fields. It also engages in petrochemicals, ethanol exports, and low-carbon energy initiatives.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $11.61 on June 3rd, 2025.
- Our designated price target stands at $20.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
Balfour Capital Group wants to clarify that our recommendation to Buy Petroleo Brasileiro SA Petrobras (NYSE: PBR)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
TTWO
Take-Two Interactive Software
(NASDAQ: TTWO)
Balfour Capital Group has issued a buy recommendation
for Take-Two Interactive Software (TTWO)Â on June 3rd, 2025
Take-Two Interactive Software, Inc. is a leading American video game holding company headquartered in New York City. Founded in 1993, it develops, publishes, and markets interactive entertainment for consumers globally. The company operates through several labels, including Rockstar Games, 2K, Private Division, and Zynga, offering products across console, PC, and mobile platforms. Notable franchises under its umbrella include Grand Theft Auto, NBA 2K, Red Dead Redemption, and Civilization.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $227.60 on June 3rd, 2025.
- Our designated price target stands at $335.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
2025 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy Take-Two Interactive Software (NASDAQ: TTWO)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
EBAY
eBay
(NASDAQ: EBAY)
Balfour Capital Group has issued a buy recommendation
for EBAY (EBAY)Â on May 21st, 2025
eBay Inc. is a global e-commerce platform that connects millions of buyers and sellers across more than 190 markets. Founded in 1995 by Pierre Omidyar, eBay enables users to buy and sell a wide range of goods and services through online auctions and fixed-price listings. The company generates revenue primarily through transaction fees, advertising, and payment processing services.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $72.59 on May 21st, 2025.
- Our designated price target stands at $95.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
XBalfour Capital Group wants to clarify that our recommendation to Buy eBay (NASDAQ: EBAY)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
SNOW
Snowflake Inc.
(NYSE: SNOW)
Balfour Capital Group has issued a buy recommendation
for Snowflake (SNOW)Â on May 21st, 2025
Snowflake Inc. is a cloud-based data platform that enables organizations to consolidate, store, and analyze data across various public clouds. Its platform supports applications in data warehousing, data lakes, data engineering, data science, and data sharing. Snowflake’s architecture separates storage and compute, allowing for scalable and flexible data management solutions.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $182.20 on May 21st, 2025.
- Our designated price target stands at $235.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
2025 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
XBalfour Capital Group wants to clarify that our recommendation to Buy Snowflake Inc. (NYSE: SNOW)Â is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
